<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0035-0052</journal-id>
<journal-title><![CDATA[Revista mexicana de pediatría]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. pediatr.]]></abbrev-journal-title>
<issn>0035-0052</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Pediatría A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0035-00522024000600216</article-id>
<article-id pub-id-type="doi">10.35366/120536</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efectividad del dispositivo intrauterino hormonal para el manejo del sangrado uterino anormal en adolescentes con enfermedad crónica]]></article-title>
<article-title xml:lang="en"><![CDATA[Effectiveness of the levonorgestrel-releasing intrauterine device for abnormal uterine bleeding in adolescents with chronic disease]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rivera-Velásquez]]></surname>
<given-names><![CDATA[Sara María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Cabezza]]></surname>
<given-names><![CDATA[Abigail]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zurita-Cruz]]></surname>
<given-names><![CDATA[Jessie N]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Centro Médico Nacional Siglo XXI Unidad Médica de Alta Especialidad Hospital de Pediatría]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Centro Médico Nacional Siglo XXI Unidad Médica de Alta Especialidad Hospital de Pediatría]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>91</volume>
<numero>6</numero>
<fpage>216</fpage>
<lpage>221</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0035-00522024000600216&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0035-00522024000600216&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0035-00522024000600216&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  Aproximadamente 20% de las adolescentes experimentan sangrado uterino anormal (SUA). Esta situación puede hacer más complejo el manejo de pacientes con alguna enfermedad crónica.  Objetivo:  Describir la efectividad del dispositivo intrauterino de tipo hormonal (DIUh) en el manejo del SUA en adolescentes con enfermedades crónicas.  Material y métodos:  Presentamos la evolución de nueve pacientes adolescentes con enfermedad crónica que cursaron con SUA y que recibieron un DIUh con levonorgestrel. Se describen las características del trastorno menstrual, tratamientos previos recibidos y la respuesta al uso del DIUh.  Resultados:  La mediana para la edad fue de 12 años. Las pacientes tenían enfermedad renal crónica, epilepsia, trastornos de la coagulación, discapacidad intelectual y/o anemia grave. Antes de la aplicación de DIUh, cinco ya habían recibido tratamientos hormonales para tratar de controlar el SUA. La indicación de colocación se basó en los criterios de elegibilidad de la Organización Mundial de la Salud para el uso de anticonceptivos reversibles de acción prolongada (LARC). Posterior a la colocación del DIUh, todas presentaron disminución significativa en la cantidad y duración del sangrado menstrual, después de tres meses del tratamiento.  Conclusiones:  El DIUh es efectivo y seguro para el manejo del SUA en adolescentes con enfermedades crónicas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Approximately 20% of adolescents experience abnormal uterine bleeding (AUB). This comorbidity can make the management of patients with chronic disease more complex.  Objective:  To describe the effectiveness of the hormonal intrauterine device (hIUD) in the management of AUB in adolescents with chronic diseases.  Material and methods:  We present the evolution of nine adolescent patients with chronic disease who presented with AUB, receiving a levonorgestrel-containing IUD. The characteristics of the menstrual disorder, previous treatments received, and response to the use of the hIUD are described.  Results:  The median age was 12 years. The patients had chronic kidney disease, epilepsy, coagulation disorders, intellectual disability, and/or severe anemia. Before insertion of the hIUD, five had already received hormonal treatments to control AUB. The indication for hIUD insertion was based on the World Health Organization eligibility criteria for long-acting reversible contraceptives (LARC). After insertion of the hIUD, all patients experienced a significant decrease in the amount and duration of menstrual bleeding three months after treatment.  Conclusions:  The hIUD is effective and safe for the management of AUB in adolescents with chronic illnesses.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[sangrado uterino anormal]]></kwd>
<kwd lng="es"><![CDATA[adolescentes]]></kwd>
<kwd lng="es"><![CDATA[dispositivo intrauterino liberador de levonorgestrel]]></kwd>
<kwd lng="es"><![CDATA[enfermedad crónica]]></kwd>
<kwd lng="en"><![CDATA[abnormal uterine bleeding]]></kwd>
<kwd lng="en"><![CDATA[adolescents]]></kwd>
<kwd lng="en"><![CDATA[levonorgestrel-releasing intrauterine device]]></kwd>
<kwd lng="en"><![CDATA[chronic disease]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Deligeoroglou]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Karountzos]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Creatsas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology]]></article-title>
<source><![CDATA[Gynecol Endocrinol]]></source>
<year>2013</year>
<volume>29</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>74-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Best]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Dunn]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Leyland]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Wolfman]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abnormal uterine bleeding in pre-menopausal women]]></article-title>
<collab>Clinical Practice - Gynaecology Committee</collab>
<source><![CDATA[J Obstet Gynaecol Can]]></source>
<year>2013</year>
<volume>35</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>473-5</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serret-Montoya]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Cabezza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Rojas]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Cárdenas-Navarrete]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Villasis-Keever]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alteraciones menstruales en adolescentes]]></article-title>
<source><![CDATA[Bol Med Hosp Infant Mex]]></source>
<year>2012</year>
<volume>69</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>63-76</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vygivska]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Rudenko]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Pliekhova]]></surname>
<given-names><![CDATA[OO]]></given-names>
</name>
<name>
<surname><![CDATA[Rakytianskyi]]></surname>
<given-names><![CDATA[IY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abnormal uterine bleeding and its causes. Literature review]]></article-title>
<source><![CDATA[Pol Merkur Lekarski]]></source>
<year>2024</year>
<volume>52</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>457-61</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Comishen]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yeung]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Irfan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sidonio]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Etiology and diagnosis of heavy menstrual bleeding among adolescent and adult patients: a systematic review and meta-analysis of the literature]]></article-title>
<source><![CDATA[J Thromb Haemost]]></source>
<year>2025</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>863-76</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serret-Montaya]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zurita-Cruz]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Villasís-Keever]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar-Kitsu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Del Carmen Zepeda-Martinez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz-Anleu]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperprolactinemia as a prognostic factor for menstrual disorders in female adolescents with advanced chronic kidney disease]]></article-title>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2020</year>
<volume>35</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1041-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wildemeersch]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Goldstuck]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Femilis(®) 60 levonorgestrel-releasing intrauterine system-a review of 10 years of clinical experience]]></article-title>
<source><![CDATA[Clin Med Insights Reprod Health]]></source>
<year>2016</year>
<volume>10</volume>
<page-range>19-27</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández-Cabezza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Serret-Montoya]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Villasis-Keever]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Bonilla-Rojas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Garrido-Magaña]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cárdenas-Navarrete]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experiencia de 15 años en ginecología pediátrica y de la adolescente en un hospital pediátrico de tercer nivel]]></article-title>
<source><![CDATA[Bol Med Hosp Infant Mex]]></source>
<year>2012</year>
<volume>69</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>391-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Medical eligibility criteria for contraceptive use]]></source>
<year>2015</year>
<edition>5th</edition>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kitahara]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Hiraike]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ishikawa]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Kugu]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Takai]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshino]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis of abnormal uterine bleeding based on the FIGO classification: A systematic review and expert opinions]]></article-title>
<source><![CDATA[J Obstet Gynaecol Res]]></source>
<year>2024</year>
<volume>50</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1785-94</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vilos]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Tureanu]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abu-Rafea]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy]]></article-title>
<source><![CDATA[J Minim Invasive Gynecol]]></source>
<year>2009</year>
<volume>16</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>480-4</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[ECF]]></given-names>
</name>
<name>
<surname><![CDATA[Baeta]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Cotta]]></surname>
<given-names><![CDATA[RCF]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[ALL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of 52-mg levonorgestrel-releasing intrauterine system in adolescents and young adult women: 3-year follow-up]]></article-title>
<source><![CDATA[J Pediatr Adolesc Gynecol]]></source>
<year>2023</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>45-50</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Krashin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Mody]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hormonal and intrauterine methods for contraception for women aged 25 years and younger]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2015</year>
<volume>2015</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>CD009805</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Callegari]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Darney]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Godfrey]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Sementi]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Dunsmoor-Su]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Prager]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evidence-based selection of candidates for the levonorgestrel intrauterine device (IUD)]]></article-title>
<source><![CDATA[J Am Board Fam Med]]></source>
<year>2014</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26-33</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pillai]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Brien]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities]]></article-title>
<source><![CDATA[BJOG]]></source>
<year>2010</year>
<volume>117</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>216-21</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Goldberg]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Grimes]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Expanding access to intrauterine contraception]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2009</year>
<volume>201</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>456.e1-5</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adeyemi-Fowode]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[XM]]></given-names>
</name>
<name>
<surname><![CDATA[Dietrich]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Srivaths]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Levonorgestrel-releasing intrauterine device use in female adolescents with heavy menstrual bleeding and bleeding disorders: single institution review]]></article-title>
<source><![CDATA[J Pediatr Adolesc Gynecol]]></source>
<year>2017</year>
<volume>30</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>479-83</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alaqzam]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Stanley]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Simpson]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Flood]]></surname>
<given-names><![CDATA[VH]]></given-names>
</name>
<name>
<surname><![CDATA[Menon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment modalities in adolescents who present with heavy menstrual bleeding]]></article-title>
<source><![CDATA[J Pediatr Adolesc Gynecol]]></source>
<year>2018</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>451-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patseadou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Michala]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Usage of the levonorgestrel-releasing intrauterine system (LNG-IUS) in adolescence: what is the evidence so far?]]></article-title>
<source><![CDATA[Arch Gynecol Obstet]]></source>
<year>2017</year>
<volume>295</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>529-41</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gemzell-Danielsson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Buhling]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Dermout]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Lukkari-Lax]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Montegriffo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Apter]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg) in postmenarcheal adolescents]]></article-title>
<source><![CDATA[Contraception]]></source>
<year>2016</year>
<volume>93</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>507-12</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zia]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rajpurkar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Challenges of diagnosing and managing the adolescent with heavy menstrual bleeding]]></article-title>
<source><![CDATA[Thromb Res]]></source>
<year>2016</year>
<volume>143</volume>
<page-range>91-100</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Secura]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Allsworth]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Madden]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Mullersman]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Peipert]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2010</year>
<volume>203</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>115.e1-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
